Perceptive Advisors - Y-MABS THERAPEUTICS INC ownership

Y-MABS THERAPEUTICS INC's ticker is YMAB and the CUSIP is 984241109. A total of 94 filers reported holding Y-MABS THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.01 and the average weighting 0.2%.

Quarter-by-quarter ownership
Perceptive Advisors ownership history of Y-MABS THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$3,057,000
-4.7%
212,0180.0%0.09%
-11.0%
Q2 2022$3,208,000
-79.1%
212,018
-40.3%
0.10%
-59.8%
Q2 2020$15,352,000
+27.0%
355,366
-32.0%
0.25%
-21.0%
Q1 2020$12,085,000
-31.2%
522,480
-7.1%
0.32%
-9.7%
Q4 2019$17,570,000
-21.1%
562,237
-34.2%
0.35%
-41.8%
Q3 2019$22,280,000854,9400.60%
Other shareholders
Y-MABS THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Memorial Sloan Kettering Cancer Center 191,176$1,041,9094.24%
Sofinnova Investments, Inc. 2,194,278$11,958,8150.75%
DENALI ADVISORS LLC 85,900$468,1550.16%
Polar Capital Holdings Plc 2,103,298$11,462,9740.08%
Soleus Capital Management, L.P. 157,182$856,6420.08%
GSA CAPITAL PARTNERS LLP 137,299$7480.06%
Caligan Partners LP 23,321$127,0990.06%
Corton Capital Inc. 12,244$66,7300.03%
RICE HALL JAMES & ASSOCIATES, LLC 91,249$497,3070.03%
CIM INVESTMENT MANAGEMENT INC 15,313$83,4560.03%
View complete list of Y-MABS THERAPEUTICS INC shareholders